Biotech startup ELMED Life Sciences has successfully raised $2.7 million in its Series A funding round, with AgriSURE Fund, managed by NABVENTURES, as the lead investor. This funding will support the company’s efforts to enhance its manufacturing capabilities, boost research and development initiatives, and expand its distribution networks both locally and globally.
ELMED Life Sciences, founded by Pruthivin Reddy Madduri and co-founded by Nikhil Konkathi, specializes in developing probiotic and biological solutions for the animal health, agriculture, aquaculture, and human health sectors. Their product portfolio aims to enhance productivity and sustainability in poultry, dairy, livestock, aquaculture, and soil health domains through innovative microbiome-based offerings.
The company’s strategic plan includes scaling up manufacturing operations in Hyderabad, reinforcing market presence in tier 2 and tier 3 regions, and bolstering international outreach to meet the rising demand for antibiotic-free and sustainable solutions globally. Currently exporting to more than 18 countries, ELMED Life Sciences operates on a business-to-business model, serving a diverse range of enterprise clients across various industries.
Source: Entrackr : Latest Posts